These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30660695)

  • 21. Screening for cocrystallization tendency: the role of intermolecular interactions.
    He G; Jacob C; Guo L; Chow PS; Tan RB
    J Phys Chem B; 2008 Aug; 112(32):9890-5. PubMed ID: 18646803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput 96-well solvent mediated sonic blending synthesis and on-plate solid/solution stability characterization of pharmaceutical cocrystals.
    Luu V; Jona J; Stanton MK; Peterson ML; Morrison HG; Nagapudi K; Tan H
    Int J Pharm; 2013 Jan; 441(1-2):356-64. PubMed ID: 23178596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate.
    Kojima T; Tsutsumi S; Yamamoto K; Ikeda Y; Moriwaki T
    Int J Pharm; 2010 Oct; 399(1-2):52-9. PubMed ID: 20696223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artificial neural networks (ANNs) and partial least squares (PLS) regression in the quantitative analysis of cocrystal formulations by Raman and ATR-FTIR spectroscopy.
    Barmpalexis P; Karagianni A; Nikolakakis I; Kachrimanis K
    J Pharm Biomed Anal; 2018 Sep; 158():214-224. PubMed ID: 29886369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
    Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
    J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advancements in Pharmaceutical Cocrystals, Preparation Methods, and their Applications.
    Manchanda D; Kumar A; Nanda A
    Curr Pharm Des; 2021; 27(44):4477-4495. PubMed ID: 33858309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cocrystal formulations: A case study of topical formulations consisting of ferulic acid cocrystals.
    Aitipamula S; Das S
    Eur J Pharm Biopharm; 2020 Apr; 149():95-104. PubMed ID: 32035236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raman and Terahertz Spectroscopic Characterization of Solid-state Cocrystal Formation within Specific Active Pharmaceutical Ingredients.
    Du Y; Xue J; Hong Z
    Curr Pharm Des; 2020; 26(38):4829-4846. PubMed ID: 32445442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical cocrystallization techniques. Advances and challenges.
    Rodrigues M; Baptista B; Lopes JA; Sarraguça MC
    Int J Pharm; 2018 Aug; 547(1-2):404-420. PubMed ID: 29890258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties.
    Grossjohann C; Serrano DR; Paluch KJ; O'Connell P; Vella-Zarb L; Manesiotis P; Mccabe T; Tajber L; Corrigan OI; Healy AM
    J Pharm Sci; 2015 Apr; 104(4):1385-98. PubMed ID: 25605031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
    Rahman Z; Samy R; Sayeed VA; Khan MA
    Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPLC determination of olanzapine and carbamazepine in their nicotinamide cocrystals and investigation of the dissolution profiles of cocrystal tablet formulations.
    Renkoğlu P; Çelebier M; Arıca-Yegin B
    Pharm Dev Technol; 2015 May; 20(3):380-4. PubMed ID: 24521464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphism of Carbamazepine Pharmaceutical Cocrystal: Structural Analysis and Solubility Performance.
    Surov AO; Drozd KV; Ramazanova AG; Churakov AV; Vologzhanina AV; Kulikova ES; Perlovich GL
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorph characterization of active pharmaceutical ingredients (APIs) using low-frequency Raman spectroscopy.
    Larkin PJ; Dabros M; Sarsfield B; Chan E; Carriere JT; Smith BC
    Appl Spectrosc; 2014; 68(7):758-76. PubMed ID: 25014842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer.
    Yamashita H; Sun CC
    Pharm Res; 2017 Dec; 35(1):4. PubMed ID: 29288433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
    Qiao N; Wang K; Schlindwein W; Davies A; Li M
    Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical Cocrystals of Ethenzamide: Molecular Structure Analysis Based on Vibrational Spectra and DFT Calculations.
    Wan M; Fang J; Xue J; Liu J; Qin J; Hong Z; Li J; Du Y
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems.
    Singh M; Barua H; Jyothi VGSS; Dhondale MR; Nambiar AG; Agrawal AK; Kumar P; Shastri NR; Kumar D
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of Cocrystallization Approach in Drug Development: Recent Patents Review.
    Shah K; Parmar VK
    Recent Pat Nanotechnol; 2018; 12(2):143-154. PubMed ID: 29473529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theophylline-nicotinamide cocrystal formation in physical mixture during storage.
    Ervasti T; Aaltonen J; Ketolainen J
    Int J Pharm; 2015; 486(1-2):121-30. PubMed ID: 25800677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.